AIC
ANGO icon

Ameritas Investment Company’s AngioDynamics ANGO Stock Holding History

Ameritas Investment Company’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-484
Closed -$10K – 981
2018
Q4 		$10K Buy
+484
New +$10K ﹤0.01% 1038

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Ameritas Investment Company's ANGO Position: Q1 2019 in Review

Ameritas Investment Company sold out of AngioDynamics (ANGO) in Q1 2019, closing a stake of 484 shares — an estimated $10K sold.

Ameritas Investment Company first reported a position in ANGO in Q4 2018 and held it in 1 quarter. The position peaked at $10K in Q4 2018. 179 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.

  • Ameritas Investment Company reported no remaining AngioDynamics position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 484 AngioDynamics shares in Q1 2019, an estimated $10K.
  • Ameritas Investment Company first reported a position in AngioDynamics in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's AngioDynamics position peaked at $10K in Q4 2018.
  • 179 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.